Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00756548 · ClinicalTrials.gov registry record · Phase 3
BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
A Phase 3 study of Colon Cancer, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 386
- Enrollment target
- 12
- Study locations
NCT00756548: Completed Phase 3 study of Colon Cancer, sponsored by Braintree Laboratories.
NCT00756548 is a Phase 3 study of Colon Cancer that has completed, run by Braintree Laboratories. The registered enrollment target is 386 participants, below the 4,452-participant average among 97 other Colon Cancer trials with a reported enrollment target (91% lower). The trial reports 12 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00756548, a Phase 3 study of Colon Cancer, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 386 participants
- Enrollment target
- 12
- Study locations
Study Summary
This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
Primary Outcome
Percentage of patients with a successful preparation (cleaning rated as "Good" or "Excellent")
Conditions Studied
Interventions
- DRUG BLI850
- DRUG polyethylene glycol 3350 based bowel preparation
Study Locations (12)
Tennessee
- Franklin Gastroenterology - Franklin
- Memphis Gastroenterology Group - Germantown
- The Frist Clinic - Nashville
California
- Advanced Clinical Research Institute - Anaheim
- Advanced Clinical Research Institute - Orange
Indiana
- Indiana University Medical Center - Indianapolis
Mississippi
- Gastrointestinal Associates - Jackson
Oklahoma
- Options Health Research - Tulsa
Oregon
- Northwest Gastroenterology Clinic - Portland
Texas
- Houston Medical Research Associates - Houston
Virginia
- Charlottesville Medical Research - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 386 participants |
| Start Date | 2008-08 |
| Phase | Phase 3 |
What the finished NCT00756548 record still lists
NCT00756548 is an interventional study that assigns participants to a tested intervention. The registered 386 participants enrollment target is mid-sized for trials with a published cap, below the 4,452-participant average among 97 other Colon Cancer trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Colon Cancer appearing as the primary indexed condition, and to 2 interventions - of which BLI850 is the first listed.
NCT00756548 lists 12 locations in 9 states (Tennessee, California, Indiana).
Frequently Asked Questions
What is clinical trial NCT00756548 about?
NCT00756548 is a clinical study titled "BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy". This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
What is the current status of trial NCT00756548?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 386 participants. The study started on 2008-08.
What conditions does trial NCT00756548 study?
This clinical trial studies the following conditions: Colon Cancer.
What interventions are being tested in trial NCT00756548?
The interventions under investigation include: BLI850 (DRUG), polyethylene glycol 3350 based bowel preparation (DRUG).
Who is sponsoring clinical trial NCT00756548?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00756548 being conducted?
This trial has 12 study locations across California, Indiana, Mississippi, Oklahoma, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00756548's enrollment target sits among peer trials
386 24th of 97 higher than 74 of 97 other Colon Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colon Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Promoting Physical Activity After Colorectal Cancer
COMPLETED · Phase 3
-
Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults
COMPLETED · Phase 3
-
An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy
COMPLETED · Phase 3
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645107 · 386 participants · Phase 3
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- NCT05896189 · 386 participants · NA
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
- NCT06686121 · 386 participants · Phase 3
Improving Mobility After Revascularization in Peripheral Artery Disease
- NCT07424547 · 386 participants · Phase 1
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia